Anne-Lise Berthier
@anne-liseberthier.bsky.social
biotech, gene therapy, oligonucleotides, PMO, cell therapy, regenerative medicine
CDC battered by government shutdown firings, while some are rescinded www.statnews.com/2025/10/11/c... via @statnews.com
CDC battered by government shutdown firings, while some are rescinded
The White House’s mass firing of CDC staff on Friday has decimated offices related to injury prevention, respiratory disease surveillance, and chronic disease, according to four people familiar with t...
www.statnews.com
October 12, 2025 at 5:54 PM
CDC battered by government shutdown firings, while some are rescinded www.statnews.com/2025/10/11/c... via @statnews.com
Merck KGaA has opened a €150 million filter manufacturing facility in Blarney Business Park, Cork, Ireland.
The cleanroom facility supports global demand for critical filtration products used in the manufacturing of vaccines and life-saving therapies. biopharmanalyses.fr/merck-kgaa-o...
The cleanroom facility supports global demand for critical filtration products used in the manufacturing of vaccines and life-saving therapies. biopharmanalyses.fr/merck-kgaa-o...
Merck KGaA opens climate-neutral €150 million filter manufacturing facility in Ireland – Biopharmanalyses
biopharmanalyses.fr
September 18, 2025 at 4:10 PM
Merck KGaA has opened a €150 million filter manufacturing facility in Blarney Business Park, Cork, Ireland.
The cleanroom facility supports global demand for critical filtration products used in the manufacturing of vaccines and life-saving therapies. biopharmanalyses.fr/merck-kgaa-o...
The cleanroom facility supports global demand for critical filtration products used in the manufacturing of vaccines and life-saving therapies. biopharmanalyses.fr/merck-kgaa-o...
Launch of www.mitogether.com, the reference website for professionals and families affected by genetic mitochondrial diseases
biopharmanalyses.fr/www-mitogeth...
biopharmanalyses.fr/www-mitogeth...
September 17, 2025 at 6:28 PM
Launch of www.mitogether.com, the reference website for professionals and families affected by genetic mitochondrial diseases
biopharmanalyses.fr/www-mitogeth...
biopharmanalyses.fr/www-mitogeth...
FDA leaders moving to abandon advisory committee reviews of specific new drugs
Critics say the move would shield the agency’s decisions from public scrutiny
www.statnews.com/2025/09/12/f...
Critics say the move would shield the agency’s decisions from public scrutiny
www.statnews.com/2025/09/12/f...
FDA leaders moving to abandon advisory committee reviews of specific new drugs
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications
www.statnews.com
September 15, 2025 at 12:57 PM
FDA leaders moving to abandon advisory committee reviews of specific new drugs
Critics say the move would shield the agency’s decisions from public scrutiny
www.statnews.com/2025/09/12/f...
Critics say the move would shield the agency’s decisions from public scrutiny
www.statnews.com/2025/09/12/f...
Roughly three months after signing an executive order to streamline the construction of drug manufacturing plants in the U.S., President Donald Trump has issued another directive aimed at shoring up the country’s pharmaceutical supply chain.
www.fiercepharma.com/manufacturin...
www.fiercepharma.com/manufacturin...
Amid tariff-fueled onshoring push, Trump signs order to boost US stockpiling of certain drug ingredients
Roughly three months after signing an executive order to streamline the | President Donald Trump has inked a new executive order calling on the HHS’ Administration for Strategic Preparedness and Respo...
www.fiercepharma.com
August 14, 2025 at 3:22 PM
Roughly three months after signing an executive order to streamline the construction of drug manufacturing plants in the U.S., President Donald Trump has issued another directive aimed at shoring up the country’s pharmaceutical supply chain.
www.fiercepharma.com/manufacturin...
www.fiercepharma.com/manufacturin...
RFK Jr. Axes 22 mRNA Vaccine Projects Under BARDA
The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA vaccine development. www.hhs.gov/press-room/h...
The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA vaccine development. www.hhs.gov/press-room/h...
www.hhs.gov
August 6, 2025 at 2:51 PM
RFK Jr. Axes 22 mRNA Vaccine Projects Under BARDA
The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA vaccine development. www.hhs.gov/press-room/h...
The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA vaccine development. www.hhs.gov/press-room/h...
Fibrosens Project to develop sensor devices for muscular dystrophy research | EurekAlert! www.eurekalert.org/news-release...
Fibrosens Project to develop sensor devices for muscular dystrophy research
IBEC researcher Juanma Fernández recently has received funding from the French AFM-Telethon to carry out the project “Monitoring of fibrotic processes in 3D skeletal muscle co-cultures fo...
www.eurekalert.org
July 31, 2025 at 1:20 PM
Fibrosens Project to develop sensor devices for muscular dystrophy research | EurekAlert! www.eurekalert.org/news-release...
Trump cuts subscriptions to Springer Nature journals | Science | AAAS www.science.org/content/arti...
Trump cuts subscriptions to Springer Nature journals
Other publishers appear unscathed in recent actions
www.science.org
June 30, 2025 at 10:08 AM
Trump cuts subscriptions to Springer Nature journals | Science | AAAS www.science.org/content/arti...
Genome of Europe launched public awareness survey on genomics across five EU countries (Estonia, France, Greece, Portugal, and Slovenia)
biopharmanalyses.fr/genome-of-eu...
biopharmanalyses.fr/genome-of-eu...
Genome of Europe launched public awareness survey on genomics across five EU countries – Biopharmanalyses
biopharmanalyses.fr
June 21, 2025 at 5:46 PM
Genome of Europe launched public awareness survey on genomics across five EU countries (Estonia, France, Greece, Portugal, and Slovenia)
biopharmanalyses.fr/genome-of-eu...
biopharmanalyses.fr/genome-of-eu...
FDA : Now Priority Vouchers will be available to companies :
- Addressing a health crisis in the U.S
- Delivering more innovative cures for the American people.
- Addressing unmet public health needs.
- Increasing domestic drug manufacturing as a national security issue.
www.fda.gov/news-events/...
- Addressing a health crisis in the U.S
- Delivering more innovative cures for the American people.
- Addressing unmet public health needs.
- Increasing domestic drug manufacturing as a national security issue.
www.fda.gov/news-events/...
FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests
DA Announces Commissioner’s National Priority Voucher Program (CNPVP)
www.fda.gov
June 17, 2025 at 4:58 PM
FDA : Now Priority Vouchers will be available to companies :
- Addressing a health crisis in the U.S
- Delivering more innovative cures for the American people.
- Addressing unmet public health needs.
- Increasing domestic drug manufacturing as a national security issue.
www.fda.gov/news-events/...
- Addressing a health crisis in the U.S
- Delivering more innovative cures for the American people.
- Addressing unmet public health needs.
- Increasing domestic drug manufacturing as a national security issue.
www.fda.gov/news-events/...
Transparent peer review to be extended to all of Nature’s research papers
From today, all new submissions to Nature that are published will be accompanied by referees’ reports and author responses — to illuminate the process of producing rigorous science. www.nature.com/articles/d41...
From today, all new submissions to Nature that are published will be accompanied by referees’ reports and author responses — to illuminate the process of producing rigorous science. www.nature.com/articles/d41...
Transparent peer review to be extended to all of Nature’s research papers
From today, all new submissions to Nature that are published will be accompanied by referees’ reports and author responses — to illuminate the process of producing rigorous science.
www.nature.com
June 17, 2025 at 9:32 AM
Transparent peer review to be extended to all of Nature’s research papers
From today, all new submissions to Nature that are published will be accompanied by referees’ reports and author responses — to illuminate the process of producing rigorous science. www.nature.com/articles/d41...
From today, all new submissions to Nature that are published will be accompanied by referees’ reports and author responses — to illuminate the process of producing rigorous science. www.nature.com/articles/d41...
Major acquisition in the mRNA area : BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
www.fiercebiotech.com/biotech/bion...
www.fiercebiotech.com/biotech/bion...
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech is buying fellow
www.fiercebiotech.com
June 12, 2025 at 2:59 PM
Major acquisition in the mRNA area : BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
www.fiercebiotech.com/biotech/bion...
www.fiercebiotech.com/biotech/bion...
Reposted by Anne-Lise Berthier
Kári Stefánsson, who last month left the Icelandic genetics company deCODE, spoke to Nature about his legacy
https://go.nature.com/447omPv
https://go.nature.com/447omPv
Genomics pioneer fired from firm he founded: ‘It was not easy to domesticate me’
Nature - Kári Stefánsson, who last month left the Icelandic genetics company deCODE, spoke to Nature about his legacy.
go.nature.com
June 11, 2025 at 9:14 AM
Kári Stefánsson, who last month left the Icelandic genetics company deCODE, spoke to Nature about his legacy
https://go.nature.com/447omPv
https://go.nature.com/447omPv
US Health Secretary Kennedy guts vaccine advisory committee www.reuters.com/business/hea...
US Health Secretary Kennedy guts vaccine advisory committee
Kennedy has fired all 17 members of a U.S. Centers for Disease Control and Prevention panel of vaccine experts and is in the process of replacing them.
www.reuters.com
June 10, 2025 at 6:28 PM
US Health Secretary Kennedy guts vaccine advisory committee www.reuters.com/business/hea...
NIH grant cuts will axe clinical trials abroad — and could leave thousands without care
US agency’s new policy could abruptly end studies of infectious diseases and cancer, leaving researchers scrambling for funds.
www.nature.com/articles/d41...
US agency’s new policy could abruptly end studies of infectious diseases and cancer, leaving researchers scrambling for funds.
www.nature.com/articles/d41...
NIH grant cuts will axe clinical trials abroad — and could leave thousands without care
US agency’s new policy could abruptly end studies of infectious diseases and cancer, leaving researchers scrambling for funds.
www.nature.com
June 3, 2025 at 6:27 PM
NIH grant cuts will axe clinical trials abroad — and could leave thousands without care
US agency’s new policy could abruptly end studies of infectious diseases and cancer, leaving researchers scrambling for funds.
www.nature.com/articles/d41...
US agency’s new policy could abruptly end studies of infectious diseases and cancer, leaving researchers scrambling for funds.
www.nature.com/articles/d41...
TreeFrog Therapeutics has secured a €30 million financing from the European Investment Bank (EIB) to support the advancement of their lead cell therapy program in Parkinson’s Disease to the clinic. biopharmanalyses.fr/treefrog-the...
TreeFrog Therapeutics secures €30 million from EIB – Biopharmanalyses
biopharmanalyses.fr
May 27, 2025 at 12:39 PM
TreeFrog Therapeutics has secured a €30 million financing from the European Investment Bank (EIB) to support the advancement of their lead cell therapy program in Parkinson’s Disease to the clinic. biopharmanalyses.fr/treefrog-the...
@GustaveRoussy launches UMBRELLA study to personnalise post-treatment follow-up for cancer patients biopharmanalyses.fr/launch-of-um...
Launch of UMBRELLA study to personnalise post-treatment follow-up for cancer patients – Biopharmanalyses
biopharmanalyses.fr
May 19, 2025 at 5:30 PM
@GustaveRoussy launches UMBRELLA study to personnalise post-treatment follow-up for cancer patients biopharmanalyses.fr/launch-of-um...
FDA commissioner says new vaccine ‘framework’ for industry is coming within weeks
The vaccines guidance will focus on Covid-19 shots, Makary says. www.statnews.com/2025/05/15/f...
The vaccines guidance will focus on Covid-19 shots, Makary says. www.statnews.com/2025/05/15/f...
FDA commissioner says new vaccine ‘framework’ for industry is coming within weeks
A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA’s expectations for vaccines.
www.statnews.com
May 15, 2025 at 4:52 PM
FDA commissioner says new vaccine ‘framework’ for industry is coming within weeks
The vaccines guidance will focus on Covid-19 shots, Makary says. www.statnews.com/2025/05/15/f...
The vaccines guidance will focus on Covid-19 shots, Makary says. www.statnews.com/2025/05/15/f...
Trump policies disrupt trials at NIH Clinical Center, researchers say. Studies of new treatments delayed at hospital focused on hard-to-treat diseases
www.statnews.com/2025/05/06/t...
www.statnews.com/2025/05/06/t...
Trump policies disrupt trials at NIH Clinical Center, researchers say
The NIH Clinical Center is struggling to carry out its mission of running clinical trials for the hardest-to-treat diseases
www.statnews.com
May 6, 2025 at 10:23 AM
Trump policies disrupt trials at NIH Clinical Center, researchers say. Studies of new treatments delayed at hospital focused on hard-to-treat diseases
www.statnews.com/2025/05/06/t...
www.statnews.com/2025/05/06/t...
FDA delays PDUFA date for small biotech, raising questions about impact of agency cuts. t.co/5cTvm0R0to
https://endpts.com/fda-delays-small-biotechs-decision-date-seemingly-due-to-agency-cuts/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content=
t.co
April 29, 2025 at 3:33 PM
FDA delays PDUFA date for small biotech, raising questions about impact of agency cuts. t.co/5cTvm0R0to
Reposted by Anne-Lise Berthier
Now online! The establishment of nuclear organization in mouse embryos is orchestrated by multiple epigenetic pathways
The establishment of nuclear organization in mouse embryos is orchestrated by multiple epigenetic pathways
In vivo screening in mouse embryos provides insights into the functional interplay between chromatin and the nuclear envelope in the establishment of lamina-associated domains, the earliest feature of nuclear organization following fertilization.
dlvr.it
April 23, 2025 at 3:00 PM
Now online! The establishment of nuclear organization in mouse embryos is orchestrated by multiple epigenetic pathways
Reposted by Anne-Lise Berthier
Draft Trump budget proposes a $20 billion NIH budget cut in 2026 and a sweeping consolidation
Trump budget draft proposes NIH consolidation and 40% spending cut
Draft Trump budget proposes a $20 billion NIH budget cut in 2026 and a sweeping consolidation
buff.ly
April 17, 2025 at 2:45 AM
Draft Trump budget proposes a $20 billion NIH budget cut in 2026 and a sweeping consolidation
Tariffs on pharmaceuticals soon ? US investigation launched to determine the effects on the national security of imports of pharmaceuticals, including finished drug products, critical inputs such as API and key starting materials.https://www.govinfo.gov/content/pkg/FR-2025-04-16/pdf/2025-06587.pdf
www.govinfo.gov
April 16, 2025 at 3:44 PM
Tariffs on pharmaceuticals soon ? US investigation launched to determine the effects on the national security of imports of pharmaceuticals, including finished drug products, critical inputs such as API and key starting materials.https://www.govinfo.gov/content/pkg/FR-2025-04-16/pdf/2025-06587.pdf
FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B. investor.precisionbiosciences.com/news-release...
Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B | Precision BioSciences
DURHAM, N.C. --(BUSINESS WIRE)--Apr. 15, 2025-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo ge...
investor.precisionbiosciences.com
April 15, 2025 at 11:06 AM
FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B. investor.precisionbiosciences.com/news-release...